Drug discovery using support vector machines. The case studies of drug-likeness, agrochemical-likeness, and enzyme inhibition predictions
Related Experiment Video
Updated: Aug 30, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Vladimir V Zernov1, Konstantin V Balakin, Andrey A Ivaschenko
1Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1, 119899 GSP-3 Moscow, Russia.
Abstract:
Support Vector Machines (SVM) is a powerful classification and regression tool that is becoming increasingly popular in various machine learning applications. We tested the ability of SVM, in comparison with well-known neural network techniques, to predict drug-likeness and agrochemical-likeness for large compound collections. For both kinds of data, SVM outperforms various neural networks using the same set of descriptors. We also used SVM for estimating the activity of Carbonic Anhydrase II (CA II) enzyme inhibitors and found that the prediction quality of our SVM model is better than that reported earlier for conventional QSAR. Model characteristics and data set features were studied in detail.
Related Concept Videos
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
